The Rheumatology Unit places a strong emphasis on the early diagnosis of inflammatory rheumatic diseases, such as arthritis, connective tissue diseases, and auto-inflammatory conditions. Detecting these diseases early is crucial because it allows for timely intervention, which can significantly improve patient outcomes and prevent the progression of the disease.
In addition to early diagnosis, the unit conducts regular monitoring of patients with inflammatory rheumatic diseases. These periodic check-ups are essential for identifying and managing risk factors that could lead to a severe prognosis. By closely monitoring these factors, the unit can proactively adjust treatment plans to manage the disease more effectively and mitigate potential complications.
Furthermore, the unit is committed to using innovative therapies and advanced therapeutic protocols. This includes the use of biologic drugs, targeted therapies, and other cutting-edge medical interventions. These innovative approaches aim to reduce inflammation, manage symptoms, and improve the quality of life for patients. The unit also participates in clinical trials to explore new treatment options and stay at the forefront of rheumatology care.
